ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Belgian chemical maker Solvay has almost completed its acquisition of Rhodia, having obtained close to 95% of the French firm’s shares from shareholders. Solvay made its $4.5 billion cash offer to buy Rhodia in April. The acquisition will nearly double Solvay’s sales and instantly expand the firm’s business in developing markets. In the U.S., meanwhile, institutional cleaning products maker Ecolab can continue its acquisition of water treatment chemicals firm Nalco, thanks to an early termination of the Hart-Scott-Rodino Antitrust waiting period granted by the Federal Trade Commission. Ecolab agreed to buy Nalco in July for $8.1 billion. Finally, conglomerate Berkshire Hathaway got clearance from European antitrust authorities to buy Ohio-based specialty chemical maker Lubrizol. Berkshire Hathaway said in March that it will pay $9.7 billion for the company. Overall, chemical firms are in a postrecession growth period, according to a recent report from consulting firm PricewaterhouseCoopers. Concerns about the global economy have moderated merger activity at the year’s halfway mark, the report says, but deals will likely accelerate in the third quarter.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X